Peter Aaby, Leder af Bandim Health Project

Statens Serum Institut
Artillerivej 5 , 206/108
2300 København S
3268 3268
Telefon:
32683950
E-mail:

Forskningsområder

Akutte infektioner og langtidsvirkninger af disse, herunder mæslinge, polio, skoldkopper, RSV, diarré, HV-2. Forebyggende helbredsprogrammer i udviklingslande, særligt vaccination, diarrékontrol og programmer for udbredelse af amning.

Udvalgte publikationer

  • Benn CS, Fisker AB, Aaby P Serious danger signals: Response to: The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial. Int J Epidemiol.2017; 46(5), 1718-1720
  • Benn CS, Sørup S, Aaby P Re: Beneficial non-specific reduction in hospital admissions for respiratory infections following MMR and MenC vaccinations in the Netherlands. BMJ rapid responses. BMJ.2017; 358,
  • Benn CS, Sørup S, Aaby P The sequence of vaccinations to test the non-specific effects of vaccines. BMJ (Rapid response).2017; 358,
  • Biering-Sørensen S, Jensen KJ, Monterio I, Ravn H, Aaby P, Benn CS Rapid protective effects of early BCG on neonatal mortality among low birth weight boys: observations from randomised trials. J Infect Dis.2017; In Press,
  • Do VA, Fisker AB, Aaby P, Benn CS, Biering-Sorensen S, Bale C, Rasmussen SM, Christensen LD; Jensen KJ, Martins C Effect of an Early Dose of Measles Vaccine on Morbidity Between 18 Weeks and 9 Months of Age: A Randomized, Controlled Trial in Guinea-Bissau. Journal of Infectious Diseases.2017; 216(2),

Publikationer

Link til Pub Med